Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Cash Flow from Operations

Bristol-Myers Squibb Company Cash Flow from Operations Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Bristol-Myers Squibb Company Cash Flow from Operations for the quarter ending September 09, 2020 was $2,219m a 8.16% increase of 181m year over year
  • Bristol-Myers Squibb Company Cash Flow from Operations for the last 12 months ending September 09, 2020 was $12,420m a 35.05% increase of 4,353m year over year
  • Bristol-Myers Squibb Company Annual Cash Flow from Operations for 2019 was $8,067m a 26.37% increase of 2,127m from 2018
  • Bristol-Myers Squibb Company Annual Cash Flow from Operations for 2018 was $5,940m a 11.20% increase of 665m from 2017
  • Bristol-Myers Squibb Company Annual Cash Flow from Operations for 2017 was $5,275m a 42.03% increase of 2,217m from 2016
Other Cash Flow Metrics:
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $628m a -33.89% decrease of -213m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Cash Flow from Operations Data

09/2020$2,219m
06/2020$4,269m
03/2020$3,894m
12/2019$2,038m
09/2019$2,556m
06/2019$2,083m
03/2019$1,390m
12/2018$2,429m
09/2018$1,279m
06/2018$1,057m

Annual BMY Cash Flow from Operations Data

2019$8,067m
2018$5,940m
2017$5,275m
2016$3,058m
2015$2,105m
2014$3,148m
2013$3,545m
2012$6,941m
2011$4,840m
2010$4,491m